New England Journal of Medicine

Diseases, Conditions, Syndromes

Iptacopan improves hematologic, clinical outcomes in persistent anemia

The first-in-class oral factor B inhibitor iptacopan improves hematologic and clinical outcomes in anti-C5-treated patients with persistent anemia and in those who have not received complement inhibitors, according to a study ...

Oncology & Cancer

Assessing breast cancer risk

The genetic risk of breast cancer has been in the news lately. Researchers at the Mayo Clinic Comprehensive Cancer Center are working toward pinpointing individuals' risk of developing breast cancer.

page 3 from 40